TWI602582B - A use of an extract of cassiopea andromeda - Google Patents

A use of an extract of cassiopea andromeda Download PDF

Info

Publication number
TWI602582B
TWI602582B TW105122644A TW105122644A TWI602582B TW I602582 B TWI602582 B TW I602582B TW 105122644 A TW105122644 A TW 105122644A TW 105122644 A TW105122644 A TW 105122644A TW I602582 B TWI602582 B TW I602582B
Authority
TW
Taiwan
Prior art keywords
jellyfish
extract
jelly
cell
preparation
Prior art date
Application number
TW105122644A
Other languages
Chinese (zh)
Other versions
TW201808265A (en
Inventor
吳裕仁
Original Assignee
吳裕仁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 吳裕仁 filed Critical 吳裕仁
Priority to TW105122644A priority Critical patent/TWI602582B/en
Priority to CN201710063221.7A priority patent/CN107625789B/en
Application granted granted Critical
Publication of TWI602582B publication Critical patent/TWI602582B/en
Publication of TW201808265A publication Critical patent/TW201808265A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

仙后水母萃取物的用途 Use of Jellyfish Jellyfish Extract

本發明係關於一種仙后水母萃取物的用途,特別關於一種仙后水母萃取物應用於製備促進皮膚細胞新生的製劑的用途。 The present invention relates to the use of a jellyfish jelly extract, and more particularly to the use of a jellyfish jelly extract for the preparation of a formulation for promoting skin cell renewal.

一般而言,健康肌膚會以28天為更新週期,然而隨著年齡增長,或受到外在環境刺激的影響,肌膚更新的速度會減緩,而使得肌膚變得粗糙或暗沉,甚至出現其他的肌膚問題,因此為了維持良好膚況,促進皮膚細胞新生確實是刻不容緩的。 In general, healthy skin will last for 28 days. However, with age, or by external environmental stimuli, the speed of skin renewal will slow down, making the skin rough or dull, and even other Skin problems, so in order to maintain a good skin condition, it is imperative to promote skin cell renewal.

因此,本發明提供一種仙后水母萃取物的用途,係將萃取自仙后水母之活性成分,應用於製備促進皮膚細胞新生的製劑者。 Accordingly, the present invention provides a use of a jellyfish jelly extract which is applied to a preparation for promoting skin cell renewal by extracting an active ingredient extracted from the jellyfish jellyfish.

本發明之仙后水母萃取物的用途,係應用於製備促進皮膚細胞新生的製劑,其中,該仙后水母萃取物係由包含以下步驟之方法萃取獲得:提供一仙后水母樣品;將該仙后水母樣品與一磷酸鹽緩衝生理鹽水共同均質後,取得一上清液;以一飽和硫酸銨溶液(飽和百分比為60~100%)沉澱該仙后水母樣品之總蛋白,並取得一沉澱物;將該沉澱物回溶於50mM之Tris-HCl緩衝液;及利用該Tris-HCl緩衝液進行透析,以去除分子量為10kDa以下的小分子物質,並將該透析產物進行冷凍乾燥。 The use of the extract of the jellyfish jelly of the present invention is for preparing a preparation for promoting skin cell regeneration, wherein the extract of the jellyfish jelly is obtained by a method comprising the steps of: providing a sample of a jellyfish jelly; After the jellyfish sample is homogenized with the monophosphate buffered saline, a supernatant is obtained; the total protein of the jellyfish sample is precipitated by a saturated ammonium sulfate solution (saturated percentage of 60-100%), and a precipitate is obtained. The precipitate was dissolved in 50 mM Tris-HCl buffer; and dialyzed against the Tris-HCl buffer to remove small molecular substances having a molecular weight of 10 kDa or less, and the dialysis product was freeze-dried.

據此,藉由萃取自仙后水母之活性成分,可以維持粒線體外膜上之膜電位平衡,提升粒線體的活性,並促進與細胞之存活相關的基因表現,因而可以促使細胞增生,並可以應用於製備促進皮膚細胞新生的製 劑,為本發明之功效。 Accordingly, by extracting the active ingredient from the jellyfish jelly, the membrane potential balance on the outer membrane of the mitochondria can be maintained, the activity of the mitochondria can be enhanced, and the gene expression associated with cell survival can be promoted, thereby promoting cell proliferation. And can be applied to the preparation of a system that promotes skin cell renewal The agent is the efficacy of the present invention.

第1a圖:仙后水母萃取物提升角質細胞株HaCat的細胞存活率。 Figure 1a: The extract of the post-mortem jellyfish enhances the cell viability of the keratinocyte strain HaCat.

第1b圖:仙后水母萃取物提升纖維母細胞株HS68的細胞存活率。 Figure 1b: The cell survival rate of the fertility of the fibroblast cell line HS68 after the extract of the jellyfish jellyfish.

第2a~2f圖:仙后水母萃取物促進角質細胞株HaCat的細胞數量。 Figures 2a~2f: The extract of the jellyfish jelly promotes the number of cells in the keratinocyte strain HaCat.

第3a~3f圖:仙后水母萃取物促進纖維母細胞株HS68的細胞數量。 Figures 3a to 3f: The extract of the jellyfish jellyfish promotes the number of cells of the fibroblast cell line HS68.

第4圖:仙后水母萃取物加速角質細胞株HaCat的細胞癒合。 Figure 4: Jellyfish jelly extract accelerates cell healing of the keratinocyte cell line HaCat.

第5a圖:仙后水母萃取物於角質細胞株HaCat中的生理機轉。 Figure 5a: Physiological transformation of the extract of the jellyfish jelly in the keratinocyte strain HaCat.

第5b圖:仙后水母萃取物於纖維母細胞株HS68中的生理機轉。 Figure 5b: Physiological transformation of the extract of the jellyfish jellyfish in the fibroblast cell line HS68.

為讓本發明之上述及其他目的、特徵及優點能更明顯易懂,下文特舉本發明之較佳實施例,並配合所附圖式,作詳細說明如下: The above and other objects, features and advantages of the present invention will become more <RTIgt;

本發明所述之「製劑」係指將一活性成分加工調製,製成特定劑型,且包含一定劑量之藥品及化妝品,而本發明所述之「促進皮膚細胞新生的製劑」則可以維持粒線體外膜上之膜電位平衡,提升粒線體的活性,並促進與細胞之存活相關的基因表現,此為本發明所屬技術領域中具有通常知識者可以理解,於此不再贅述。 The "preparation" as used in the present invention means that an active ingredient is processed and prepared into a specific dosage form, and contains a certain amount of medicines and cosmetics, and the "promoting skin cell regeneration preparation" of the present invention can maintain the granular line. The membrane potential balance on the extracorporeal membrane enhances the activity of the mitochondria and promotes gene expression associated with cell survival, which is understood by those of ordinary skill in the art to which the present invention pertains, and will not be further described herein.

本發明之仙后水母萃取物係可以指仙后水母之總蛋白經濃縮所獲得之產物。詳而言之,所述「仙后水母」係為倒立水母科(Cassioidae)的仙后水母(Cassiopea andromeda),其身體及口腕具有共生藻(蟲黃藻),該些共生藻可以行光合作用,以作為仙后水母的最主要營養來源。 The extract of the jellyfish jelly of the present invention may refer to a product obtained by concentrating the total protein of the jellyfish jellyfish. In detail, the "Queen Jellyfish" is the Cassiopea and Romeda of the Cassioidae family, and its body and wrist have symbiotic algae ( Hymenoptera ), which can be photosynthetic Role, as the most important source of nutrition for the queen jellyfish.

於本實施例中,該仙后水母萃取物係藉由一包含以下步驟之方法所製得:將完整的仙后水母個體(包含共生藻)作為一仙后水母樣品,取100克之仙后水母樣品混合100毫升之一磷酸鹽緩衝生理鹽水(phosphate buffer saline,簡稱PBS),以經預冷之果汁機共同均質後,離心以取得一上清液(轉速為6,000~10,000rpm);續於該上清液中加入一硫酸銨溶液(飽和百分比為60~100%),使該仙后水母樣品中所含有的總蛋白得以形成一沉澱物,並離心以取得該沉澱物(轉速為6,000~10,000rpm);接著利用50mM之Tris-HCl緩衝液回溶該沉澱物;最終於低溫下利用5公升之Tris-HCl緩衝液進行透析,以去除分子量為10kDa以下的小分子物質,並避免該沉澱物中的鹽類對後續實驗造成干擾,並將該透析產物進行冷凍乾燥,以獲得該仙后水母萃取物。為了維持該仙后水母萃取物的活性,前述製得方法的各步驟均係於4℃下進行。 In the present embodiment, the extract of the queenfish jellyfish is obtained by a method comprising the steps of: taking a complete post-mortem jellyfish (including symbiotic algae) as a sample of a jellyfish jellyfish, and taking 100 grams of the jellyfish jellyfish. Sample mixed with 100 ml of phosphate buffered saline (phosphate Buffer saline (referred to as PBS), after homogenization by pre-cooled juice machine, centrifuge to obtain a supernatant (rotation speed of 6,000 ~ 10,000 rpm); continue to add ammonium sulfate solution to the supernatant (saturation percentage is 60~100%), the total protein contained in the Jellyfish sample is formed into a precipitate, and centrifuged to obtain the precipitate (rpm 6,000-10,000 rpm); then, using 50 mM Tris-HCl buffer back Dissolving the precipitate; finally dialysis using 5 liters of Tris-HCl buffer at low temperature to remove small molecular substances having a molecular weight of 10 kDa or less, and avoiding the salt in the precipitate from interfering with subsequent experiments, and The dialysis product is freeze-dried to obtain the extract of the jellyfish. In order to maintain the activity of the extract of the jellyfish jelly, each step of the above preparation method was carried out at 4 °C.

本發明之仙后水母萃取物,係可以維持粒線體外膜上之膜電位平衡,提升粒線體的活性,並促進與細胞之存活相關的基因表現,因而可以促使細胞增生,並可以應用於製備促進皮膚細胞新生的製劑,該仙后水母萃取物可以與至少一醫藥學上可接受之載體共同組成該製劑,或是於該製劑中額外添加他種美白之活性成分,以共同投予一所需個體,該載體係為一賦型劑或一添加劑,較佳係可以共同形成液狀、乳液狀、乳霜狀或膠狀等各種型態之製劑,進而能夠便於該所需個體的使用。 The extract of the jellyfish of the present invention can maintain the membrane potential balance on the outer membrane of the mitochondria, enhance the activity of the mitochondria, and promote the gene expression related to the survival of the cells, thereby promoting cell proliferation and can be applied to Preparing a preparation for promoting skin cell regeneration, the post-mortem jelly extract may be combined with at least one pharmaceutically acceptable carrier to form the preparation, or an additional active ingredient of the whitening agent may be added to the preparation for co-administering one The desired individual, the carrier is an excipient or an additive, and preferably can form a preparation of various forms such as a liquid, an emulsion, a cream or a gel, thereby facilitating the use of the desired individual. .

為證實本發明之仙后水母萃取物確實具有促進皮膚細胞新生的活性,遂以角質細胞(keratinocyte)株HaCat、纖維母細胞(fibroblast)株HS68作為模式細胞株,進行以下試驗: In order to confirm that the extract of the jellyfish jelly of the present invention does have an activity of promoting skin cell regeneration, the keratinocyte strain HaCat and the fibroblast strain HS68 were used as model cell strains, and the following tests were carried out:

(A)對皮膚細胞之細胞存活率的影響: (A) Effect on cell viability of skin cells:

請參照第1表所示,將該仙后水母萃取物回溶於該磷酸鹽緩衝生理鹽水後,加入前述模式細胞株中,於培養24小時後,以MTT分析法計算各組模式細胞株的細胞存活率,結果分別如第1a、1b圖所示。 Referring to the first table, the extract of the queenfish jellyfish is dissolved in the phosphate buffered saline, and then added to the model cell strain. After 24 hours of culture, the cell strains of each group are calculated by MTT assay. Cell viability, the results are shown in Figures 1a and 1b, respectively.

第1表、本試驗各組的試驗條件。 Table 1 and test conditions for each group of the test.

請參照第1a、1b圖所示,無論是HaCat細胞或HS68細胞,該仙后水母萃取物的添加均可以促進細胞的存活。 Referring to Figures 1a and 1b, the addition of the extract of the queenfish jelly can promote cell survival, whether it is HaCat cells or HS68 cells.

(B)對皮膚細胞之細胞增生的影響: (B) Effects on cell proliferation of skin cells:

續請參照第2表所示,將該仙后水母萃取物加入前述模式細胞株中,於培養24小時後,以顯微鏡觀察視野下的細胞數量,結果分別如第2a~3f圖所示。 Continued, as shown in Table 2, the extract of the queenfish jellyfish was added to the above-mentioned model cell strain, and after 24 hours of culture, the number of cells in the visual field was observed by a microscope, and the results are shown in Fig. 2a to 3f, respectively.

請參照第2a~2f圖所示,該仙后水母萃取物的添加可以促進HaCat細胞的增生,且如第3a~3f圖所示,於HS68細胞亦可以觀察到相同的結果。 Please refer to Figures 2a~2f for the addition of the extract of the Jellyfish to promote the proliferation of HaCat cells, and the same results can be observed in HS68 cells as shown in Figures 3a-3f.

(C)對皮膚細胞之傷口癒合的影響: (C) Effects on wound healing of skin cells:

另請參照第3表所示,將該仙后水母萃取物加入HaCat細胞中,分別於培養12、24、36、48小時後,觀察該仙后水母萃取物對於傷口癒合的效果,結果如第4圖所示。 Please also refer to the third table, the extract of the jellyfish jelly was added to HaCat cells, and after 12, 24, 36, and 48 hours of culture, the effect of the extract of the jellyfish jelly on wound healing was observed. Figure 4 shows.

請參照第4圖所示,該仙后水母萃取物的添加可以促進HaCat細胞的傷口癒合,且其促進效果明顯具有劑量依賴性。 Referring to Fig. 4, the addition of the extract of the jellyfish jelly can promote wound healing of HaCat cells, and the promoting effect thereof is obviously dose-dependent.

(D)仙后水母萃取物的作用機制: (D) Mechanism of action of the extract of the jellyfish jellyfish:

此外,請參照第4表所示,將該仙后水母萃取物加入前述模式細胞株中,於培養24小時後,收集各組細胞的細胞溶解液,以西方墨點法偵測與粒線體活性、細胞存活之相關目標蛋白的蛋白質表現量,結果分別如第5a、5b圖所示。 In addition, please refer to the fourth table, add the extract of the jellyfish jelly to the above-mentioned model cell strain, and after 24 hours of culture, collect the cell lysate of each group of cells, and detect and mitochondria by Western blotting method. The protein expression of the target protein related to activity and cell survival is shown in Figures 5a and 5b, respectively.

請參照第5a圖所示,於HaCat細胞中,仙后水母萃取物的 添加可以提升抑制細胞凋亡路徑之Bcl-2、Mcl-1、Bcl-xL、Ki-67、存活素(Survivin)、STAT等蛋白質的表現,並降低促進細胞凋亡路徑之Bad、Bax等蛋白質的表現,而仙后水母萃取物的添加同時亦可以促進端粒酶(telomerase)的蛋白質表現,顯示仙后水母萃取物可以維持粒線體外膜上之膜電位平衡,提升粒線體的活性,並促進細胞的存活。且如第5b圖所示,於HS68細胞亦可以觀察到相同的結果。 Please refer to Figure 5a for the extraction of the jellyfish jelly in HaCat cells. Adding Bcl-2, Mcl-1, Bcl-xL, Ki-67, Survivin, STAT and other proteins that inhibit the apoptotic pathway, and reducing the protein such as Bad and Bax that promote the apoptotic pathway The performance of the extract of the jellyfish jelly can also promote the protein expression of telomerase, indicating that the extract of the jellyfish jelly can maintain the membrane potential balance on the outer membrane of the mitochondria and enhance the activity of the mitochondria. And promote cell survival. As shown in Figure 5b, the same results were observed in HS68 cells.

綜合上述,藉由萃取自仙后水母之活性成分,可以維持粒線體外膜上之膜電位平衡,提升粒線體的活性,並促進與細胞之存活相關的基因表現,因而可以促使細胞增生,並可以應用於製備促進皮膚細胞新生的製劑,為本發明之功效。 In summary, by extracting the active ingredient from the jellyfish jelly, the membrane potential balance on the outer membrane of the mitochondria can be maintained, the activity of the mitochondria can be enhanced, and the gene expression associated with cell survival can be promoted, thereby promoting cell proliferation. It can also be applied to the preparation of a preparation for promoting skin cell renewal, which is an effect of the present invention.

雖然本發明已利用上述較佳實施例揭示,然其並非用以限定本發明,任何熟習此技藝者在不脫離本發明之精神和範圍之內,相對上述實施例進行各種更動與修改仍屬本發明所保護之技術範疇,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described in connection with the preferred embodiments described above, it is not intended to limit the scope of the invention. The technical scope of the invention is protected, and therefore the scope of the invention is defined by the scope of the appended claims.

Claims (1)

一種仙后水母萃取物的用途,係應用於製備促進皮膚細胞新生的製劑,其中,該仙后水母萃取物係由包含以下步驟之方法萃取獲得:提供一仙后水母樣品;將該仙后水母樣品與一磷酸鹽緩衝生理鹽水共同均質後,取得一上清液;以一硫酸銨溶液(飽和百分比為60~100%)沉澱該仙后水母樣品之總蛋白,並取得一沉澱物;將該沉澱物回溶於50mM之Tris-HCl緩衝液;及利用該Tris-HCl緩衝液進行透析,以去除分子量為10kDa以下的小分子物質,並將該透析產物進行冷凍乾燥。 The use of a jellyfish jelly extract for preparing a preparation for promoting skin cell regeneration, wherein the extract of the centipede jellyfish is obtained by a method comprising the steps of: providing a sample of a jellyfish jelly; the jellyfish jellyfish After the sample is homogenized with the phosphate buffered saline, a supernatant is obtained; the total protein of the extract of the jellyfish is precipitated with an ammonium sulfate solution (saturated percentage of 60-100%), and a precipitate is obtained; The precipitate was dissolved in 50 mM Tris-HCl buffer; and dialyzed using the Tris-HCl buffer to remove small molecular substances having a molecular weight of 10 kDa or less, and the dialysis product was freeze-dried.
TW105122644A 2016-07-18 2016-07-18 A use of an extract of cassiopea andromeda TWI602582B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW105122644A TWI602582B (en) 2016-07-18 2016-07-18 A use of an extract of cassiopea andromeda
CN201710063221.7A CN107625789B (en) 2016-07-18 2017-02-03 Use of extract of post-immortal jellyfish

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW105122644A TWI602582B (en) 2016-07-18 2016-07-18 A use of an extract of cassiopea andromeda

Publications (2)

Publication Number Publication Date
TWI602582B true TWI602582B (en) 2017-10-21
TW201808265A TW201808265A (en) 2018-03-16

Family

ID=61011226

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105122644A TWI602582B (en) 2016-07-18 2016-07-18 A use of an extract of cassiopea andromeda

Country Status (2)

Country Link
CN (1) CN107625789B (en)
TW (1) TWI602582B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111011575B (en) * 2019-12-30 2023-03-31 广州市科能化妆品科研有限公司 Jellyfish growth promoting peptide and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009090655A2 (en) * 2008-01-16 2009-07-23 Coll-Med Ltd Colloidal collagen burn wound dressing produced from jellyfish

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103819552B (en) * 2014-02-17 2016-01-13 中国人民解放军第二军医大学 A kind of Cyanea capillata polypeptide growth factor and its preparation method and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009090655A2 (en) * 2008-01-16 2009-07-23 Coll-Med Ltd Colloidal collagen burn wound dressing produced from jellyfish

Also Published As

Publication number Publication date
TW201808265A (en) 2018-03-16
CN107625789B (en) 2020-03-10
CN107625789A (en) 2018-01-26

Similar Documents

Publication Publication Date Title
Bagood et al. TRPV1: role in skin and skin diseases and potential target for improving wound healing
CN102639129B (en) Antimicrobial compositions containing free fatty
CN107530317A (en) The combination of Cannabinoids and N acyl ethanol amines
Li et al. Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway
Miazga-Karska et al. Anti-acne action of peptides isolated from burdock root—preliminary studies and pilot testing
WO2016159593A2 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containing lactococcus chungangensis as active ingredient
Zhang et al. Ginsenoside Rg1 inhibits oxidative stress and inflammation in rats with spinal cord injury via Nrf2/HO-1 signaling pathway
JP6611291B2 (en) Novel antibacterial peptides and uses thereof
TW201200137A (en) Use of isoacteoside or pharmaceutically acceptable salt thereof in inhibiting formation, accumulation or aggregation of amyloid beta peptides, and in fabrication of drug for preventing or treating amyloid beta peptide-associated diseases or conditions
TWI602582B (en) A use of an extract of cassiopea andromeda
WO2018113272A1 (en) Pharmaceutical composition comprising oxytocin analog, preparation method therefor, and use thereof
Zhuang et al. NLRP3 inflammasome as a potential therapeutic target in dry eye disease
CN105920044A (en) Hydra stem cell preparation as well as preparation method and application thereof
CA2910103C (en) Topical composition for enhancing skin sensitivity and use thereof
CN105769754A (en) Metronidazole gel free of preservative and preparation method thereof
JP2017128540A (en) Sea grape extract inhibiting allergy, method for preparing the same, and application of the same
JP2017226615A (en) Antibacterial composition and method for producing the same
CN116889582B (en) Application of composition in preparation of medicines for treating ischemic cerebral apoplexy
RU2741948C1 (en) Method for preventing hypercoagulation in animals under stress
RU2673555C2 (en) Method for application yagel detox dietary supplement as means for treatment of multiple drug resistance tuberculosis
US20220079999A1 (en) Antivenom compositions and uses thereof
CN109806288B (en) Use of aqueous extracts of equatorial cherry
PECK et al. Trichophytin: I. Methods of Preparation with Special Reference to the Specific Skin-Reactive Factor
RU2453321C1 (en) Preparation for treating animals with anti-inflammatory and antibacterial actions
Chand et al. Therapeutic management of blood transfusion reaction in a crossbred cow